Inogen ROE 2012-2025 | INGN
Current and historical return on equity (ROE) values for Inogen (INGN) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Inogen ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-03-31 | $-0.03B | $0.20B | -15.03% |
| 2024-12-31 | $-0.04B | $0.17B | -20.03% |
| 2024-09-30 | $-0.05B | $0.19B | -28.05% |
| 2024-06-30 | $-0.09B | $0.19B | -46.08% |
| 2024-03-31 | $-0.10B | $0.19B | -43.41% |
| 2023-12-31 | $-0.10B | $0.21B | -41.53% |
| 2023-09-30 | $-0.13B | $0.23B | -49.08% |
| 2023-06-30 | $-0.10B | $0.28B | -32.23% |
| 2023-03-31 | $-0.09B | $0.28B | -27.99% |
| 2022-12-31 | $-0.08B | $0.30B | -24.65% |
| 2022-09-30 | $-0.05B | $0.35B | -13.93% |
| 2022-06-30 | $-0.03B | $0.36B | -7.59% |
| 2022-03-31 | $-0.02B | $0.36B | -5.37% |
| 2021-12-31 | $-0.01B | $0.37B | -1.88% |
| 2021-09-30 | $0.01B | $0.39B | 3.00% |
| 2021-06-30 | $0.00B | $0.37B | -0.84% |
| 2021-03-31 | $-0.01B | $0.36B | -1.42% |
| 2020-12-31 | $-0.01B | $0.35B | -1.71% |
| 2020-09-30 | $0.00B | $0.35B | -0.57% |
| 2020-06-30 | $0.01B | $0.35B | 2.02% |
| 2020-03-31 | $0.01B | $0.35B | 4.09% |
| 2019-12-31 | $0.02B | $0.35B | 6.25% |
| 2019-09-30 | $0.03B | $0.34B | 9.78% |
| 2019-06-30 | $0.04B | $0.33B | 13.05% |
| 2019-03-31 | $0.05B | $0.32B | 15.46% |
| 2018-12-31 | $0.05B | $0.31B | 18.67% |
| 2018-09-30 | $0.04B | $0.29B | 15.91% |
| 2018-06-30 | $0.03B | $0.27B | 13.32% |
| 2018-03-31 | $0.03B | $0.25B | 11.09% |
| 2017-12-31 | $0.02B | $0.23B | 9.42% |
| 2017-09-30 | $0.03B | $0.22B | 12.94% |
| 2017-06-30 | $0.02B | $0.21B | 12.99% |
| 2017-03-31 | $0.02B | $0.19B | 13.55% |
| 2016-12-31 | $0.02B | $0.18B | 12.82% |
| 2016-09-30 | $0.02B | $0.16B | 13.19% |
| 2016-06-30 | $0.02B | $0.15B | 12.36% |
| 2016-03-31 | $0.01B | $0.14B | 9.81% |
| 2015-12-31 | $0.01B | $0.13B | 9.32% |
| 2015-09-30 | $0.01B | $0.13B | 7.21% |
| 2015-06-30 | $0.01B | $0.13B | 6.63% |
| 2015-03-31 | $0.01B | $0.12B | 6.01% |
| 2014-12-31 | $0.01B | $0.12B | 4.43% |
| 2014-09-30 | $0.03B | $0.11B | 26.74% |
| 2014-06-30 | $0.02B | $0.11B | 33.45% |
| 2013-12-31 | $0.02B | $0.06B | 142.86% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.173B | $0.336B |
| Inogen Inc. develops, manufactures and markets POC. POCs are used by patients who suffer from chronic respiratory conditions and need long-term oxygen therapy. POCs concentrate the air around the patient, filter out the nitrogen and other unwanted substances and deliver oxygen. The company provides oxygen concentrator solutions for portable and stationary use. Inogen's flagship product, One G4 is a single-solution POC. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $197.969B | 86.71 |
| Thermo Fisher Scientific (TMO) | United States | $152.062B | 18.39 |
| Edwards Lifesciences (EW) | United States | $45.884B | 30.08 |
| Alcon (ALC) | Switzerland | $42.389B | 28.65 |
| IDEXX Laboratories (IDXX) | United States | $41.285B | 47.44 |
| DexCom (DXCM) | United States | $33.643B | 52.00 |
| IQVIA Holdings (IQV) | United States | $24.277B | 13.60 |
| STERIS (STE) | Ireland | $24.122B | 26.57 |
| Mettler-Toledo (MTD) | United States | $24.015B | 28.56 |
| Waters (WAT) | United States | $20.783B | 29.32 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.675B | 0.00 |
| Hologic (HOLX) | United States | $13.854B | 15.05 |
| Sysmex ADR (SSMXY) | Japan | $10.550B | 29.93 |
| Penumbra (PEN) | United States | $10.339B | 81.15 |
| Masimo (MASI) | United States | $8.811B | 32.50 |
| Globus Medical (GMED) | United States | $8.012B | 19.09 |
| Teleflex (TFX) | United States | $5.403B | 8.92 |
| Glaukos (GKOS) | United States | $5.388B | 0.00 |
| TransMedics (TMDX) | United States | $4.300B | 93.47 |
| Integer Holdings (ITGR) | United States | $4.144B | 21.71 |
| PROCEPT BioRobotics (PRCT) | United States | $3.209B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.358B | 14.04 |
| Veracyte (VCYT) | United States | $2.084B | 29.24 |
| Nihon Kohden (NHNKY) | Japan | $2.062B | 23.65 |
| Elekta AB (EKTAY) | Sweden | $1.996B | 17.94 |
| Alphatec Holdings (ATEC) | United States | $1.817B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.320B | 0.00 |
| Artivion (AORT) | United States | $1.263B | 118.32 |
| Pulse Biosciences (PLSE) | United States | $1.164B | 0.00 |
| OPKO Health (OPK) | United States | $1.079B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.984B | 5.23 |
| SiBone (SIBN) | United States | $0.805B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.747B | 0.00 |
| IRadimed (IRMD) | United States | $0.736B | 37.34 |
| RxSight (RXST) | United States | $0.621B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.581B | 9.04 |
| Delcath Systems (DCTH) | United States | $0.565B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.549B | 12.87 |
| AxoGen (AXGN) | United States | $0.496B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.485B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.446B | 11.87 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.441B | 0.00 |
| NeuroPace (NPCE) | United States | $0.434B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.414B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.361B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.331B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.289B | 0.00 |
| Neuronetics (STIM) | United States | $0.257B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.230B | 13.91 |
| Alpha Tau Medical (DRTS) | Israel | $0.210B | 0.00 |
| 908 Devices (MASS) | United States | $0.204B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.191B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.176B | 0.00 |
| CVRx (CVRX) | United States | $0.173B | 0.00 |
| LENSAR (LNSR) | United States | $0.160B | 0.00 |
| Accuray (ARAY) | United States | $0.158B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.153B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.153B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.150B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.146B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.100B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.092B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.086B | 0.00 |
| InspireMD (NSPR) | Israel | $0.078B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 47.60 |
| EDAP TMS S.A (EDAP) | France | $0.067B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.063B | 0.00 |
| Positron (POSC) | United States | $0.054B | 0.00 |
| Hyperfine (HYPR) | United States | $0.047B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
| Spectral AI (MDAI) | United States | $0.041B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.025B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.23 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |